Last reviewed · How we verify
Neomycin Colistin Nystatin Vancomycin
At a glance
| Generic name | Neomycin Colistin Nystatin Vancomycin |
|---|---|
| Also known as | 375 mg Neomycin, 100 mg Colistin Sulphate, 1 million units Nystatin *, 250 mg Vancomycin * |
| Sponsor | Rambam Health Care Campus |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired Infections (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: